# Ian Chi Kei Wong

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ian-chi-kei-wong/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,472 |
| Field | Pharmaceutical studies and practices |
| h-index | 86 |
| i10-index | 546 |
| Last Known Institution | Macau University of Science and Technology |
| OpenAlex ID | https://openalex.org/A5079729727 |
| ORCID iD | https://orcid.org/0000-0001-8242-0014 |
| Works | 1,150 |

## Researcher papers

- [Nonpharmacological Interventions for ADHD: Systematic Review and Meta-Analyses of Randomized Controlled Trials of Dietary and Psychological Treatments](https://scholariq.org/papers/nonpharmacological-interventions-for-adhd-systematic-review-and-meta-analyses-of/)
- [Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post‐Fracture Treatment, and All‐Cause Mortality](https://scholariq.org/papers/global-epidemiology-of-hip-fractures-secular-trends-in-incidence-rate-post/)
- [European guidelines on managing adverse effects of medication for ADHD](https://scholariq.org/papers/european-guidelines-on-managing-adverse-effects-of-medication-for-adhd/)
- [Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases](https://scholariq.org/papers/trends-in-attention-deficit-hyperactivity-disorder-medication-use-a/)
- [Neurofeedback for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials](https://scholariq.org/papers/neurofeedback-for-attention-deficit-hyperactivity-disorder-meta-analysis-of/)
- [Vulnerability and resilience in children during the COVID-19 pandemic](https://scholariq.org/papers/vulnerability-and-resilience-in-children-during-the-covid-19-pandemic/)
- [Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study](https://scholariq.org/papers/bell-s-palsy-following-vaccination-with-mrna-bnt162b2-and-inactivated-coronavac/)
- [Short- and potential long-term adverse health outcomes of COVID-19: a rapid review](https://scholariq.org/papers/short-and-potential-long-term-adverse-health-outcomes-of-covid-19-a-rapid-review/)
- [ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group](https://scholariq.org/papers/adhd-management-during-the-covid-19-pandemic-guidance-from-the-european-adhd/)

## Researcher topics

- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)
- [Attention Deficit Hyperactivity Disorder](https://scholariq.org/topics/attention-deficit-hyperactivity-disorder/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Researcher university

- [Macau University of Science and Technology](https://scholariq.org/institutions/macau-university-of-science-and-technology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.